Lumida
/ANAB
⌘K
AnaptysBio Inc

AnaptysBio Inc

ANAB
$56.28USD-1.76%-1.01 today

MARKET CAP

1.6B

P/E (TTM)

FWD P/E

DAY RANGE

$55 – $57

52W RANGE

$17
$73

AI Summary

Stalk
Sell NowMedium

ANAB has broken down below the 9- and 20-day EMAs and the 50-day SMA, marking a shift into structural repair. The medium-term bias is bearish, supported by an active Bearish Pivot Point and a pattern of Lower Highs & Lower Lows. Short-term price rejection at EMAs and declining short-term trends favor immediate sell-side engagement. Under the Speculative framework, optimal execution is on rallies into the short-term EMA and 50-day SMA resistance zones.

  • Robust share momentum reflects growing investor confidence in ANAB.
  • Analysts have recently upgraded earnings estimates, indicating rising optimism.
  • Negative earnings yield underscores weak return generation.
Full analysis →
Insider Trades42 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Mar 27, 2026SellANABDaniel FagaPresident, CEO17,679$61.61$1.6B-23.22%+229.00%$1.1M-0.35%Trim
Feb 11, 2026SellANABEric J LoumeauCHIEF LEGAL OFFICER20,000$41.85$1.6B-23.22%+229.00%$837.0K+0.00%10b5-1Trim
Jan 8, 2026SellANABEric J LoumeauCHIEF LEGAL OFFICER2,210$44.71$1.6B-23.22%+229.00%$98.8K-6.76%Trim
Jan 8, 2026SellANABDennis MulroyCHIEF FINANCIAL OFFICER2,515$44.71$1.6B-23.22%+229.00%$112.4K-5.66%Trim
Jan 8, 2026SellANABPaul F. LizzulChief Medical Officer3,650$44.71$1.6B-23.22%+229.00%$163.2K-5.12%Trim
Jan 8, 2026SellANABDaniel FagaPresident, CEO14,281$44.71$1.6B-23.22%+229.00%$638.5K-2.49%Trim
Jan 7, 2026SellANABDennis MulroyCHIEF FINANCIAL OFFICER1,908$45.11$1.6B-23.22%+229.00%$86.1K-2.54%Trim
Jan 7, 2026SellANABPaul F. LizzulChief Medical Officer2,235$45.11$1.6B-23.22%+229.00%$100.8K-2.33%Trim
Jan 7, 2026SellANABDaniel FagaPresident, CEO9,202$45.11$1.6B-23.22%+229.00%$415.1K-1.27%Trim
Jan 7, 2026SellANABEric J LoumeauCHIEF LEGAL OFFICER9,639$45.56$1.6B-23.22%+229.00%$439.2K-9.40%10b5-1Trim
Jan 5, 2026SellANABEric J LoumeauCHIEF LEGAL OFFICER2,983$43.26$1.6B-23.22%+229.00%$129.0K-9.68%Trim
Jan 5, 2026SellANABDennis MulroyCHIEF FINANCIAL OFFICER3,363$43.26$1.6B-23.22%+229.00%$145.5K-9.81%Trim
Jan 5, 2026SellANABPaul F. LizzulChief Medical Officer4,219$43.26$1.6B-23.22%+229.00%$182.5K-7.20%Trim
Jan 5, 2026SellANABDaniel FagaPresident, CEO15,309$43.26$1.6B-23.22%+229.00%$662.3K-2.82%Trim
Dec 22, 2025SellANABPaul F. LizzulChief Medical Officer3,000$34.25$1.6B-23.22%+229.00%$102.8K+0.00%10b5-1Trim
Dec 22, 2025SellANABEric J LoumeauCHIEF LEGAL OFFICER20,000$32.51$1.6B-23.22%+229.00%$650.2K+0.00%10b5-1Trim
Dec 22, 2025SellANABDennis MulroyCHIEF FINANCIAL OFFICER20,000$35.08$1.6B-23.22%+229.00%$701.6K+0.00%10b5-1Trim
Dec 16, 2025SellANABDennis MulroyCHIEF FINANCIAL OFFICER25,725$35.25$1.6B-23.22%+229.00%$906.9K-4.52%10b5-1Trim
Dec 16, 2025SellANABEric J LoumeauCHIEF LEGAL OFFICER45,141$30.77$1.6B-23.22%+229.00%$1.4M-0.07%10b5-1Trim
Sep 30, 2025SellANABEric J LoumeauCHIEF LEGAL OFFICER13,240$23.34$1.6B-23.22%+229.00%$309.1K-3.32%10b5-1Trim
Jan 3, 2025SellANABEric J LoumeauCHIEF LEGAL OFFICER5,211$14.90$1.6B-23.22%+229.00%$77.6K-3.54%Trim
Jan 3, 2025SellANABDennis MulroyCHIEF FINANCIAL OFFICER5,461$14.86$1.6B-23.22%+229.00%$81.2K-3.24%Trim
Jan 3, 2025SellANABPaul F. LizzulChief Medical Officer6,597$14.84$1.6B-23.22%+229.00%$97.9K-2.88%Trim
Jan 3, 2025SellANABDaniel FagaPresident, CEO19,420$14.83$1.6B-23.22%+229.00%$288.0K-1.35%Trim
Sep 23, 2024SellANABPaul F. LizzulChief Medical Officer3,000$28.59$1.6B-23.22%+229.00%$85.8K+0.00%10b5-1Trim
Sep 16, 2024SellANABPaul F. LizzulChief Medical Officer2,220$38.93$1.6B-23.22%+229.00%$86.4K-12.60%Trim
Sep 16, 2024SellANABEric J LoumeauCHIEF LEGAL OFFICER17,500$32.15$1.6B-23.22%+229.00%$562.6K-6.65%10b5-1Trim
Sep 16, 2024SellANABDennis MulroyCHIEF FINANCIAL OFFICER22,220$31.02$1.6B-23.22%+229.00%$689.3K-2.07%10b5-1Trim
Aug 14, 2024SellANABPaul F. LizzulChief Medical Officer4,000$29.25$1.6B-23.22%+229.00%$117.0K+0.00%10b5-1Trim
Jul 18, 2024SellANABPaul F. LizzulChief Medical Officer3,000$26.75$1.6B-23.22%+229.00%$80.3K+0.00%10b5-1Trim
May 22, 2024SellANABDennis MulroyCHIEF FINANCIAL OFFICER1,500$23.72$1.6B-23.22%+229.00%$35.6K-60.88%10b5-1Trim
Mar 22, 2024SellANABDaniel FagaCEO496,381$21.95$1.6B-23.22%+229.00%$10.9M-20.69%Trim
Feb 16, 2024SellANABEric J LoumeauCHIEF LEGAL OFFICER10,000$19.51$1.6B-23.22%+229.00%$195.1K+0.00%10b5-1Trim
Jan 30, 2024SellANABDennis MulroyCHIEF FINANCIAL OFFICER3,065$23.63$1.6B-23.22%+229.00%$72.4K-76.07%10b5-1Trim
Jan 8, 2024SellANABDennis MulroyChief Financial Officer2,180$21.81$1.6B-23.22%+229.00%$47.5K-9.93%Trim
Jan 8, 2024SellANABEric J LoumeauChief Legal Officer2,305$21.81$1.6B-23.22%+229.00%$50.3K-10.39%Trim
Jan 8, 2024SellANABPaul F. LizzulChief Medical Officer2,554$21.81$1.6B-23.22%+229.00%$55.7K-8.21%Trim
Jan 8, 2024SellANABDaniel FagaCEO6,866$21.81$1.6B-23.22%+229.00%$149.7K-0.72%Trim
Nov 22, 2023SellANABEric J LoumeauChief Legal Officer882$14.19$1.6B-23.22%+229.00%$12.5K-100.00%10b5-1Trim
Sep 14, 2023SellANABPaul F. LizzulChief Medical Officer2,105$19.48$1.6B-23.22%+229.00%$41.0K-14.39%Trim
Sep 14, 2023SellANABEric J LoumeauChief Legal Officer6,000$19.37$1.6B-23.22%+229.00%$116.2K-33.98%10b5-1Trim
Sep 14, 2023SellANABDennis MulroyChief Financial Officer6,000$19.37$1.6B-23.22%+229.00%$116.2K-33.66%10b5-1Trim